At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year outcomes of the Evolut transfemoral transcatheter aortic valve replacement ...

A Tennessee mother’s pregnancy experience is serving as a powerful reminder of the importance of monitoring heart health during pregnancy.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...

We recently published an article titled Top 12 Stocks to Buy According to Citadel Investment Group. In this article, we are ...

Jones Financial Companies Lllp lifted its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 19.9% during the ...

The global oxygen conservation devices market is on an impressive growth trajectory, with industry experts forecasting a robust compound annual growth rate (CAGR) of 12% over the next decade. Valued ...

A groundbreaking heart procedure at MedStar Union Memorial Hospital has made Maryland history. Joan Mertz, 83, became the first patient in the state to undergo an artificial heart valve replacement ...

The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

An Infirmary Health doctor has been the first person to perform a TriClip G4 procedure in Mobile successfully and one of the first to perform it in the region, News 5 has learned.